Wudang sees 45.33% growth in health and pharmaceutical industry in H1

In the first six months of 2023, Wudang district's health and pharmaceutical industry experienced explosive growth of 45.33 percent year-on-year, with the output value of enterprises above designated size of 3.39 billion yuan ($465.45 million) and added value of 1.19 billion yuan.

In recent years, Wudang district in Guiyang, the capital of Southwest China's Guizhou province, has taken the health and pharmaceutical industry as its main focus. It is also the only district in the city to place such a strong emphasis on this industry.

Based on its current industry for Chinese-patented medicine, the district has promoted the construction of a modern Chinese medicine industrial system integrating the research, development and production of such patented medicines, formula granules, and other related products from China.

In order to help resolve challenges in R&D innovation, technological breakthroughs, and achievement transformation faced by local pharmaceutical enterprises, Wudang has fully supported key pharmaceutical enterprises in carrying out improvements to their drug-production processes, classic formula development, and medical insurance.

This is expected to accelerate the use of soft power such as enterprise transformation and upgrading, digital transformation, and green production, and enhance the competitiveness of local or resident enterprises.

Wudang has also paid close attention to eight key health and pharmaceutical industry projects, including the Sinopharm Western Medical Industrial Park and Xintian Pharmaceutical Traditional Chinese Medicine Formula Granules. It has also made every effort to promote the early completion and early operation of said projects.

The plans for Wudang are to initially form a health and pharmaceutical industrial belt focusing on "Chinese patent medicine, Chemical preparations and medical devices", double the industrial output value from 2021, and build a national small and medium-sized enterprise special industrial cluster.